logo

KURA

Kura Oncology·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

KURA fundamentals

Kura Oncology (KURA) released its earnings on Nov 4, 2025: revenue was 20.75M (YoY 0.00%), missed estimates; EPS was -0.85 (YoY -34.92%), missed estimates.
Revenue / YoY
20.75M
0.00%
EPS / YoY
-0.85
-34.92%
Report date
Nov 4, 2025
KURA Earnings Call Summary for Q3,2025
  • Zifduminib Regulatory Momentum: On track for November 30 FDA decision; COMET-001 data shows 70%+ CR/MRD negativity in relapsed AML.
  • Frontline Expansion: COMET-017 trials enrolling 150+ sites, targeting 50% of AML cases with Zifduminib combinations.
  • Financial Strength: $609M pro forma cash; $420M in near-term milestones from Kyowa Kirin partnership.
  • Commercial Readiness: 100+ field reps trained; launch materials and limited distribution network ready post-approval.
  • FTI Growth Potential: Darlefarinib combinations show 33-50% ORR in renal cancer; tebufarinib + alpelisib achieves 47% ORR in head/neck cancer.
EPS
Revenue

Revenue & Expenses

KURA has released its 2025 Q3 earnings report, with revenue of 20.75M, reflecting a YoY change of NaN%, and net profit of -74.12M, showing a YoY change of -36.23%. The Sankey diagram below clearly presents KURA's revenue sources and cost distribution.

Key Indicators

Kura Oncology (KURA) key financial stats and ratios, covering profitability, financial health, and leverage.
Kura Oncology (KURA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Kura Oncology (KURA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Kura Oncology (KURA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Kura Oncology (KURA) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Kura Oncology (KURA) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield